Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-04-08 @ 8:54 AM
Study NCT ID:
NCT00079950
Status:
SUSPENDED
Last Update Posted:
2012-09-06
First Post:
2004-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Sponsor:
Enzon Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CAM-9009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Senior Director, Regulatory Affairs
Old Organization:
Enzon Pharmaceuticals